None
Quote | Artelo Biosciences Inc. (OTCMKTS:ARTL)
Last: | $ |
---|---|
Change Percent: | 2.11% |
Open: | $1.58 |
Close: | $1.45 |
High: | $1.58 |
Low: | $1.45 |
Volume: | 48,173 |
Last Trade Date Time: | 02/12/2020 04:34:00 pm |
News | Artelo Biosciences Inc. (OTCMKTS:ARTL)
2024-03-25 09:05:34 ET More on Artelo Biosciences Seeking Alpha’s Quant Rating on Artelo Biosciences Historical earnings data for Artelo Biosciences Financial information for Artelo Biosciences Read the full article on Seeking Alpha For further...
SOLANA BEACH, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological condi...
Message Board Posts | Artelo Biosciences Inc. (OTCMKTS:ARTL)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $RMED News Article - Ra Medical Electrophysiology Division is Participating in EHRA Con | whytestocks | investorshangout | 04/17/2023 12:35:59 PM |
Added | heyitsmeagain | investorshub | 04/03/2023 5:45:12 PM |
Im back ! Im in pamp | heyitsmeagain | investorshub | 03/31/2023 8:12:14 PM |
whytestocks: $RMED News Article - Ra Medical Systems Announces Date of Special Shareholder Meeting | whytestocks | investorshangout | 02/10/2023 6:05:48 PM |
whytestocks: $RMED News Article - Ra Medical Systems Announces the Presentation of Clinical Data at | whytestocks | investorshangout | 01/23/2023 3:50:54 PM |
News, Short Squeeze, Breakout and More Instantly...
Artelo Biosciences Inc. Company Name:
ARTL Stock Symbol:
OTCMKTS Market:
Artelo Biosciences Inc. Website:
SOLANA BEACH, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological condi...
SOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today ...
SOLANA BEACH, CA / ACCESSWIRE / February 15, 2024 / Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that it w...